No Data
No Data
Express News | Supernus Pharmaceuticals Affirms FY2025 Sales Guidance of $600.00M-$630.00M Vs $624.69M Est
Supernus Pharmaceuticals | 10-Q: Quarterly report
Earnings Flash (SUPN) Supernus Pharmaceuticals Reports Q1 Revenue $149.8M, Vs. FactSet Est of $147.9M
Supernus Pharmaceuticals | 8-K: Supernus Announces First Quarter 2025 Financial Results
Supernus Pharmaceuticals GAAP EPS of -$0.21 Misses by $0.24, Revenue of $149.9M Beats by $1.96M
Express News | Supernus Pharmaceuticals Q1 Adjusted Operating Earnings USD 25.9 Million Vs. IBES Estimate USD 24.1 Million